Meta-analysis: budesonide treatment for collagenous colitis

Alimentary Pharmacology & Therapeutics
B FeyenR S Reyes

Abstract

Collagenous colitis is typified by chronic watery diarrhoea and characteristic histological alterations of the colonic mucosa without endoscopic abnormalities. Budesonide, a corticosteroid with high first-pass metabolism has been examined in collagenous colitis, but studies to date have had small numbers, and relatively low statistical power. A meta-analysis of existing published trials was undertaken to evaluate the treatment effect of budesonide in collagenous colitis. All pertinent literature sources were searched for published reports in English of budesonide use in collagenous colitis. MEDLINE and EMBASE databases were reviewed, as well as bibliographies from published articles and available abstracts from relevant meetings. Literature that met prespecified criteria was selected for the meta-analysis. Three trials were included in the meta-analysis. Budesonide significantly decreased stool frequency (budesonide vs. placebo OR: 20.1, 95% CI: 7.0-57.5, P < 0.0001). In general, budesonide treatment was well-tolerated. Budesonide is clinically effective short-term in collagenous colitis, and seems to be relatively well-tolerated. Clinicians can consider this drug as a reasonable option for patients with this disorder.

References

Aug 1, 1996·Histopathology·A Jawhari, I C Talbot
Feb 7, 2001·European Journal of Gastroenterology & Hepatology·W J Tremaine
Apr 25, 2000·Journal of Clinical Gastroenterology·W J Tremaine
Jun 1, 2000·Inflammatory Bowel Diseases·G F BonnerW B Ruderman
Nov 9, 2000·Alimentary Pharmacology & Therapeutics·C PapiL Capurso
Dec 23, 2000·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·J BohrG Järnerot
Mar 31, 2001·The American Journal of Gastroenterology·L M FiedlerN Harpaz
May 31, 2001·Inflammatory Bowel Diseases·G R Lichtenstein
May 23, 2002·Digestive Diseases and Sciences·Margret AgnarsdottirJon Gunnlaugur Jonasson
Jun 27, 2003·Scandinavian Journal of Gastroenterology·L K MunckB Fischer Hansen

❮ Previous
Next ❯

Citations

Jun 6, 2007·Current Treatment Options in Gastroenterology·John R Stroehlein
Aug 1, 1995·Gastroenterology·G JärnerotS Eriksson
Jan 5, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·Ole Haagen NielsenJørgen Rask-Madsen
Apr 5, 2013·Inflammatory Bowel Diseases·Fernando Fernández-BañaresUNKNOWN RECOMINA Project, GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa)
Jun 16, 2012·Case Reports in Medicine·Kaouther Ben AbdelghaniLeith Zakraoui
Jul 20, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Henrik HjortswangMagnus Ström
Aug 29, 2009·European Journal of Internal Medicine·P JobseR J L F Loffeld
Mar 21, 2006·Gastrointestinal Endoscopy Clinics of North America·Sunanda Kane
Jun 14, 2005·Alimentary Pharmacology & Therapeutics·S MiehlkeM Stolte
Nov 25, 2005·Alimentary Pharmacology & Therapeutics·S MiehlkeM Stolte
Feb 24, 2007·Pharmacotherapy·Geoffrey C WallMichael J Page
Jun 2, 2006·Arthritis and Rheumatism·Javier NarváezJosé Valverde
Dec 17, 2008·Scandinavian Journal of Gastroenterology·Olafur A SveinssonJon Gunnlaugur Jonasson
Nov 9, 2019·United European Gastroenterology Journal·Thomas De CorteFilip Baert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.